ArticleTherapeutic advances in hematology2021

Discontinuation of the renin-angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.

George Pavlidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.